Australia cracks down on unproven cell therapies
As in the US, unproven stem cell therapies have been marketed in Australia. Last week, the Therapeutic Goods Administration (TGA, similar to US FDA) of the Australian Government tightened regulations around advertising autologous (self) human cell and tissue products. As of July 1, 2018, these products cannot be marketed to consumers, and adverse events must be reported to the TGA. Read the announcement here and an article about it here.